|
ACVR2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.193900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.076000E-01 |
| Normal-vs-Stage2 |
4.286800E-01 |
| Normal-vs-Stage3 |
7.588600E-01 |
| Normal-vs-Stage4 |
9.582200E-01 |
| Stage1-vs-Stage2 |
6.973600E-01 |
| Stage1-vs-Stage3 |
3.248000E-01 |
| Stage1-vs-Stage4 |
6.301800E-01 |
| Stage2-vs-Stage3 |
3.626400E-01 |
| Stage2-vs-Stage4 |
5.676200E-01 |
| Stage3-vs-Stage4 |
8.883600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.247230E-01 |
| Normal-vs-AfricanAmerican |
2.536600E-01 |
| Normal-vs-Asian |
3.359000E-01 |
| Caucasian-vs-AfricanAmerican |
9.788000E-01 |
| Caucasian-vs-Asian |
3.467000E-01 |
| AfricanAmerican-vs-Asian |
3.460800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.601800E-01 |
| Normal-vs-Female |
2.516000E-02 |
| Male-vs-Female |
1.086040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.547000E-01 |
| Normal-vs-Extreme_Weight |
8.090400E-01 |
| Normal-vs-Obese |
5.319800E-02 |
| Normal-vs-Extreme_Obese |
8.910000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.113200E-01 |
| Normal_Weight-vs-Obese |
1.967840E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.674400E-01 |
| Extreme_Weight-vs-Obese |
3.647700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.983600E-01 |
| Obese-vs-Extreme_Obese |
4.297800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.207600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.721660E-02 |
| Normal-vs-Age(61-80Yrs) |
7.030600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.427000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.923400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.056000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.768390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.022100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.304600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.228600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.140700E-03 |
| Normal-VS-Type2 PRCC |
5.724600E-03 |
| Normal-VS-KIRP CIMP |
1.356110E-03 |
| Normal-VS-Unclassified PRCC |
2.832800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.77490000474734E-09 |
| Type1 PRCC-VS-KIRP CIMP |
3.089200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.168600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.11299999999848E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.665840E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.169600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.516370E-01 |
| Normal-vs-N1 |
5.600400E-01 |
| Normal-vs-N2 |
8.378800E-01 |
| N0-vs-N1 |
9.076300E-02 |
| N0-vs-N2 |
4.721800E-01 |
| N1-vs-N2 |
9.009200E-01 |
|
|
